Belgium
5 Vaccines Approved for Use in Belgium
Protein Subunit
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: ema.europa.eu
5 in Clinical Trials in Belgium
Protein Subunit
Clover
SCB-2019
12 trials in 11 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
Protein Subunit
OSE Immunotherapeutics
CoVepiT
3 Vaccines with Trials in Belgium are No Longer Progressing
RNA
Curevac
CVnCoV
9 trials in 12 countries
Replicating Viral Vector
Institut Pasteur
COVID-19-101
Replicating Viral Vector
Merck Sharp & Dohme Corp
V591
2 trials in 3 countries